Background: SSc (scleroderma) is a multisystemic autoimmune chronic connective tissue disease of unknown aetiopathogenesis. SSc is characterized by microvascular damage, dysregulation of innate and adaptive immunity and generalized fibrosis of the skin and internal organs. P2X7 receptor (P2X7R) is a nucleotide-gated ionotropic channel chiefly involved in the inflammatory response triggered by passive release of adenosine triphosphate from damaged cells. It is largely expressed on inflammatory cells and plays a key role in promoting the release of pro-inflammatory cytokines such as IL-1b and IL-6. P2X7R is also expressed on human dermal fibroblasts and may play a role in promoting tissue fibrosis in different body districts. Since innate immunity activation and IL-1b and IL-6 release seem to play a relevant role in SSc, we hypothesized P2X7R involvement in the pathogenesis of the disease. Methods: Human dermal fibroblasts were isolated from the skin of SSc patients and healthy subjects matched for age and sex. In these cells we evaluated P2X7R expression by quantitative RT-PCR and flow cytometry assay and P2X7R function, induced by P2X7R stimulation, as determined by cytoplasmatic free Ca 2þ concentration measurements (single-cell fluorescent microscopy), collagen production and cytokine (IL-1b and IL-6) release by ELISA. Results: P2X7R expression and Ca 2þ influxes, induced by the selective P2X7R agonist BzATP, were higher in SSc patients than in healthy control fibroblasts. Moreover, in SSc patients, BzATP stimulation enhanced the production of collagen from lipopolysaccharide (LPS)-primed fibroblasts. Interestingly, we noted that in LPS-primed SSc fibroblasts, the effect of BzATP was completely abrogated by coincubation with the P2X7R antagonist oATP, resulting in a marked antifibrotic effect. In addition, collagen production does not seem driven by the P2X7R-mediated cytokine synthesis but by ERK-1/2 signalling activation. Conclusion: Our results provide evidence that in fibroblasts from SSc patients, both the expression and function of the purinergic P2X7 receptor are increased with respect to healthy controls. These results confirm our hypothesis of an involvement of P2X7 receptors in the pathogenesis of SSc. In particular, by enhancing collagen production in SSc fibroblasts, P2X7R may promote the fibrotic process associated with the disease. These findings increase our knowledge of the pathophysiology of SS, suggesting P2X7R as a potentially attractive target for pharmacological modulation. 
